Liberia will receive an untested experimental drug, Zmapp, to treat people infected with Ebola.
According to the Liberian Government, the White House and the United States Food and Drug Administration have approved the request for sample doses of experimental Serum to treat Liberian doctors who are currently infected with the deadly Ebola virus disease.
The Executive Director of the World Health Organization, Dr. Margaret Chan, has authorized the dispatch of additional doses of the experimental Serum to Liberia to support the treatment of affected doctors. The experimental Serum from the WHO will be brought in by one of its experts later this week.
Ebola virus disease (EVD) or Ebola hemorrhagic fever (EHF) is the human disease caused by the Ebola virus. Symptoms typically start two days to three weeks after contracting the virus, with a fever, sore throat, muscle pains, and headaches. Typically nausea, vomiting, and diarrhea follow, along with decreased functioning of the liver and kidneys.
The virus may be acquired upon contact with blood or bodily fluids of an infected animal (commonly monkeys or fruit bats).
Watch the below video to know about Ebola, how Ebola spread, how to prevent Ebola, early symptoms of Ebola Virus Diseases (EVD), Diagnosis of Ebola, treatment of Ebola, and about Ebola outbreak in west africa countries such as Guinea, Sierra Leone, Liberia and Nigeria.
